Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 4 3Phase 2 2Phase 3 1Phase 2/3 1

Status

Withdrawn 8Completed 5Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Retinoblastoma 1Peripheral Nervous System Diseases 1Breast Neoplasms 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Cryotherapy × Clear all
NCT00110110 2024-04-17

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

The Hospital for Sick Children

Phase 2 Unknown
71 enrolled
Other solid neoplasm

Retinoblastoma

NCT02230319 2015-10-01

Prevention of Paclitaxel Neuropathy With Cryotherapy

Medical Oncology & Hematology Associates of Northern Virginia

Phase 2 Unknown
39 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡